Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 5/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.63 |
| ▸ | GFER | P55789 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | MITF | O75030 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.56 |
| ▸ | S100B | P04271 | 1/20 | 0.56 |
| ▸ | GABRP | O00591 | 1/20 | 0.55 |
| ▸ | GABRD | O14764 | 1/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.55 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.55 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31000389 | 1.00 | RECQL (0.67) | RECQLMAPTPOLBGAAGFER | |
| SCHEMBL145366 | 1.00 | RECQL (0.67) | RECQLMAPTPOLBGAAGFER | |
| Hydrazine SCHEMBL11821861 | 0.98 | RECQL (0.65) | RECQLMAPTPOLBGAAGFER | |
| Hydrochloric Acid SCHEMBL27581315 | 0.98 | RECQL (0.65) | RECQLMAPTPOLBGAAGFER | |
| Acetamide SCHEMBL16335345 | 0.93 | RECQL (0.59) | RECQLMAPTPOLBGAAGFER | |
| SCHEMBL6351799 | 0.91 | RECQL (0.64) | RECQLMAPTPOLBGAAGFER | |
| SCHEMBL28751447 | 0.91 | RECQL (0.56) | RECQLMAPTPOLBGAAGFER | |
| SCHEMBL12653273 | 0.87 | RECQL (0.60) | RECQLMAPTPOLBGAAGFER | |
| SCHEMBL31366555 | 0.87 | MAPT (0.61) | RECQLMAPTPOLBGAAALDH1A1 | |
| SCHEMBL1041696 | 0.87 | MAPT (0.61) | RECQLMAPTPOLBGAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116377458-A | Method for electrochemically synthesizing quinazoline derivative | 安徽科技学院 | 2023-07-04 | — | — | CN | claimed |
| EP-4608817-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-09-03 | — | — | EP | disclosed |
| US-20250213700-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR CELL-SPECIFIC PHARMACOLOGY | FOX CHASE CHEMICAL DIVERSITY CENTER, INC. | 2025-07-03 | — | — | US | disclosed |
| CN-118388387-B | Synthesis method of indole compounds | 无锡学院 | 2025-03-14 | — | — | CN | disclosed |
| CN-119072467-A | Novel diazapine compounds targeting yellow fever virus non-structural 4B (NS 4B) protein and methods of use thereof | 巴鲁克斯布伦博格研究所 | 2024-12-03 | — | — | CN | disclosed |
| CN-118388387-A | Synthesis method of indole compounds | 无锡学院 | 2024-07-26 | — | — | CN | disclosed |
| CN-118027042-A | Organic electroluminescent compound and organic electroluminescent device comprising the same | 罗门哈斯电子材料韩国有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2024091450-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-05-02 | — | — | WO | disclosed |
| CN-111094508-B | Organic electroluminescent compound and organic electroluminescent device comprising the same | 罗门哈斯电子材料韩国有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117088888-A | Preparation method of alprazolam and impurity LAP thereof | 山东安信制药有限公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-116377458-A | Method for electrochemically synthesizing quinazoline derivative | 安徽科技学院 | 2023-07-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213700-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR CELL-SPECIFIC PHARMACOLOGY | DDT, ABCG2, CES2 | RECQL 2139/4885MAPT 2568/4885POLB 2859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.